COVID-19 vaccination in South Africa: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Vaccine trails update 1
Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
Trails Update
Tags: Mobile edit Mobile web edit Advanced mobile edit
Line 199: Line 199:
|[[Johnson & Johnson COVID-19 vaccine]]
|[[Johnson & Johnson COVID-19 vaccine]]
| Viral vector
| Viral vector
| N/A
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
Line 205: Line 205:
|[[Pfizer–BioNTech COVID-19 vaccine]]
|[[Pfizer–BioNTech COVID-19 vaccine]]
| RNA
| RNA
| N/A
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
Line 213: Line 213:
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| N/A
| {{yes C| Completed}}
|-
|-
|[[Novavax COVID-19 vaccine]]
|[[Novavax COVID-19 vaccine]]
| Subunit
| Subunit
| N/A
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{operational|In progress}}
| {{operational|In progress}}
Line 223: Line 223:
|[[GRAd-COV2]]
|[[GRAd-COV2]]
| Viral vector
| Viral vector
| N/A
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{yes C| Completed}}
| {{operational|In progress}}
|-
|[[SCB-2019]]
| Subunit
| {{yes C| Completed}}
| {{operational|In progress}}
| {{operational|In progress}}
| {{operational|In progress}}
|-
|-
Line 256: Line 250:


==== Oxford–AstraZeneca ([[Oxford–AstraZeneca COVID-19 vaccine|AZD1222]]) ====
==== Oxford–AstraZeneca ([[Oxford–AstraZeneca COVID-19 vaccine|AZD1222]]) ====
Both Phase I and Phase II were conducted in South Africa.<ref name=":13">{{Cite web|title=Janssen (Johnson & Johnson): Ad26.COV2.S – COVID19 Vaccine Tracker|url=https://covid19.trackvaccines.org/vaccines/1/#trial-nct04765384|access-date=2021-05-08|website=covid19.trackvaccines.org}}</ref>Phase 1 and 2 trails began mid June 2020 consisting of about 2,130 participants.<ref>{{Cite journal|last=University of Oxford|date=2020-11-23|others=Medical Research Council, South Africa, Bill and Melinda Gates Foundation, Wits Health Consortium (Pty) Ltd, University of Witwatersrand, South Africa|title=An Adaptive Phase I/II Randomized Placebo-controlled Trial to Determine Safety, Immunogenicity and Efficacy of Non-replicating ChAdOx1 SARS-CoV-2 Vaccine in South African Adults Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV|url=https://clinicaltrials.gov/ct2/show/NCT04444674}}</ref> The trail revealed that the vaccine does not have at least 60% efficacy against mild-moderate Covid-19 due to the B.1.351 (501Y.V2) variant. This resulted in the vaccine being suspended and the 1 million doses derived being sold to other Members of the African Union.<ref>{{Cite journal|last=Voysey|first=Merryn|last2=Clemens|first2=Sue Ann Costa|last3=Madhi|first3=Shabir A.|last4=Weckx|first4=Lily Y.|last5=Folegatti|first5=Pedro M.|last6=Aley|first6=Parvinder K.|last7=Angus|first7=Brian|last8=Baillie|first8=Vicky L.|last9=Barnabas|first9=Shaun L.|last10=Bhorat|first10=Qasim E.|last11=Bibi|first11=Sagida|date=2021-01-09|title=Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK|url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/abstract|journal=The Lancet|language=English|volume=397|issue=10269|pages=99–111|doi=10.1016/S0140-6736(20)32661-1|issn=0140-6736|pmid=33306989}}</ref><ref>{{Cite web|title=Latest - Oxford Covid-19 vaccine trial results - Wits University|url=https://www.wits.ac.za/covid19/covid19-news/latest/oxford-covid-19-vaccine-trial-results.html|access-date=2021-05-08|website=www.wits.ac.za}}</ref><ref>{{Cite web|title=South African Oxford AstraZeneca Covid-19 vaccine study a global game-changer|url=https://www.eurekalert.org/pub_releases/2021-03/uotw-sao031721.php|access-date=2021-05-08|website=EurekAlert!|language=en}}</ref>

On 6 February 2021, [[The Financial Times]] reported that provisional trial data from a study undertaken by [[South Africa|South Africa's]][[University of the Witwatersrand]] in conjunction with [[University of Oxford|Oxford University]] demonstrated reduced efficacy of the [[Oxford–AstraZeneca COVID-19 vaccine]] against the [[501.V2 variant]]. The study found that in a sample size of 2,000 the [[Oxford–AstraZeneca COVID-19 vaccine|AZD1222]] vaccine afforded only "minimal protection" in all but the most severe cases of [[COVID-19]].<ref>{{cite news|last1=Booth|first1=William|last2=Johnson|first2=Carolyn Y.|date=7 February 2021|title=South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant|work=[[The Washington Post]]|location=London|url=https://www.washingtonpost.com/world/europe/astrazeneca-oxford-vaccine-south-african-variant/2021/02/07/e82127f8-6948-11eb-a66e-e27046e9e898_story.html|access-date=2021-02-08|quote=''South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.''}}</ref>
On 6 February 2021, [[The Financial Times]] reported that provisional trial data from a study undertaken by [[South Africa|South Africa's]][[University of the Witwatersrand]] in conjunction with [[University of Oxford|Oxford University]] demonstrated reduced efficacy of the [[Oxford–AstraZeneca COVID-19 vaccine]] against the [[501.V2 variant]]. The study found that in a sample size of 2,000 the [[Oxford–AstraZeneca COVID-19 vaccine|AZD1222]] vaccine afforded only "minimal protection" in all but the most severe cases of [[COVID-19]].<ref>{{cite news|last1=Booth|first1=William|last2=Johnson|first2=Carolyn Y.|date=7 February 2021|title=South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant|work=[[The Washington Post]]|location=London|url=https://www.washingtonpost.com/world/europe/astrazeneca-oxford-vaccine-south-african-variant/2021/02/07/e82127f8-6948-11eb-a66e-e27046e9e898_story.html|access-date=2021-02-08|quote=''South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.''}}</ref>


Line 266: Line 262:


==== ReiThera([[GRAd-COV2]]) ====
==== ReiThera([[GRAd-COV2]]) ====
Phase II and Phase III trails of the GRAd-COV2 vaccine are being conducted in South Africa.<ref>{{Cite web|title=ReiThera: GRAd-COV2 – COVID19 Vaccine Tracker|url=https://covid19.trackvaccines.org/vaccines/13/#trial-euctr2020-005915-39|access-date=2021-05-08|website=covid19.trackvaccines.org}}</ref><ref>{{Cite web|title=ReiThera GRAd-COV2 vaccine|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-005915-39/IT|url-status=live|access-date=8 May 2021|website=clinicaltrialsregister}}</ref>

==== SCB-2019([[SCB-2019]]) ====
A trail for the SBC-2019 vaccine developed by Clover Pharmaceuticals are currently in trail in South Africa


==== ImmunityBio ([[ImmunityBio]]) ====
==== ImmunityBio ([[ImmunityBio]]) ====
The [[Biovac A|BioVac]] Institute, a state-backed [[South Africa|South African]] vaccine company, plans to use a deal it won to manufacture [[COVID-19 vaccine|coronavirus vaccines]]. The contract with [[United States|American]] based [[ImmunityBio]] Inc is currently conducting phase 1 vaccine trials with their hAd5 vaccine in the [[United States]] and [[South Africa]].<ref>{{Cite news|date=2021-03-19|title=Covid-19 to Serve as Platform for South African Vaccine Industry|language=en|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-03-19/immunitybio-to-have-covid-19-vaccine-made-in-south-africa|access-date=2021-03-20}}</ref>
The [[Biovac A|BioVac]] Institute, a state-backed [[South Africa|South African]] vaccine company, plans to use a deal it won to manufacture [[COVID-19 vaccine|coronavirus vaccines]]. The contract with [[United States|American]] based [[ImmunityBio]] Inc is currently conducting phase 1 vaccine trials with their hAd5 vaccine in the [[United States]] and [[South Africa]].<ref>{{Cite news|date=2021-03-19|title=Covid-19 to Serve as Platform for South African Vaccine Industry|language=en|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-03-19/immunitybio-to-have-covid-19-vaccine-made-in-south-africa|access-date=2021-03-20}}</ref><ref>{{Cite web|last=Fisher|first=Shamiela|title=Nzimande excited about vaccine partnership between Biovac & ImmunityBio|url=https://ewn.co.za/2021/03/18/nzimande-announces-manufacturing-partnership-between-sa-s-biovac-and-us-firm-immunitybio|access-date=2021-03-20|website=ewn.co.za|language=en}}</ref><ref>{{Cite web|last=Sguazzin|first=Antony|title=SA's BioVac to use deal with US-based ImmunityBio to boost local vaccine creation, CEO says|url=https://www.news24.com/fin24/companies/health/sas-biovac-to-use-deal-with-us-based-immunitybio-to-boost-local-vaccine-creation-ceo-says-20210320|access-date=2021-03-20|website=Fin24|language=en-US}}</ref>


ImmunityBio is currently conducting Phase I and Phase II trails. Trails began January 2021 consisting of about only 35 participants in Phase I.<ref name=":14">{{Cite journal|last=ImmunityBio, Inc.|date=2021-03-09|title=Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of a Prophylactic COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults (ProVIVA-SA-1)|url=https://clinicaltrials.gov/ct2/show/NCT04710303}}</ref><ref name=":13" /><ref name=":14" />
[[ImmunityBio]] and [[Biovac A|BioVac]] plan to distribute the vaccines throughout [[South Africa|South African]] and [[Africa]].<ref>{{Cite web|last=Fisher|first=Shamiela|title=Nzimande excited about vaccine partnership between Biovac & ImmunityBio|url=https://ewn.co.za/2021/03/18/nzimande-announces-manufacturing-partnership-between-sa-s-biovac-and-us-firm-immunitybio|access-date=2021-03-20|website=ewn.co.za|language=en}}</ref><ref>{{Cite web|last=Sguazzin|first=Antony|title=SA's BioVac to use deal with US-based ImmunityBio to boost local vaccine creation, CEO says|url=https://www.news24.com/fin24/companies/health/sas-biovac-to-use-deal-with-us-based-immunitybio-to-boost-local-vaccine-creation-ceo-says-20210320|access-date=2021-03-20|website=Fin24|language=en-US}}</ref>


=== Johnson & Johnson Consignment (Phase III) ===
=== Johnson & Johnson Consignment (Phase III) ===

Revision as of 18:32, 8 May 2021

COVID-19 vaccination in South Africa is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 pandemic in South Africa
Native name Sisonke Protocol (Phase III J&J)
Date17 February 2021 - present
Time(SAST (GMT +2))
LocationSouth Africa South Africa
CauseCOVID-19 pandemic
BudgetR10 billion (Distribution 2021)
R2.2 billion (Q1 2021 purchasing vaccines)
R1.25 billion (Q2 2021 purchasing vaccines)
USD $1,000,000,000[1][2][3]
Organised byDepartment of Health (South Africa) & Government of South Africa
Participants381,171 total doses administered of
Johnson & Johnson/Janssen
Pfizer–BioNTech
(7 May 2021)
  • 381,171 people with at least 1 dose administered
  • 381,171 people fully vaccinated
Outcome
WebsiteVaccine Enrollment Platform
Part of a series on the
COVID-19 pandemic
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Timeline
2019
2020
2021
2022
2023
2024
Locations
By country and territory
By conveyance
International response
National responses
Medical response
Vaccines
Current vaccines
Variants
Variants of concern
Other variants
Economic impact and recession
By country
By sport
Impacts
Society
virus icon COVID-19 portal
Johnson & Johnson COVID-19 vaccine used in South Africa

On 17 February 2021, South Africa started its national vaccination program against Covid-19. The program will go through in phases, prioritizing healthcare and frontline workers and then those over the age of 65. According to health officials, South Africa has administered 381,171 vaccine doses across the country as of 7 May 2021.[5][6]South Africa has accepted delivery of 3 different vaccines, Johnson and Johnson, Pfizer-BioNTech and Oxford-AstraZeneca, administering both Johnson and Johnson and Pfizer-BioNTech, with the Oxford-AstraZeneca vaccine suspended, due to its ineffectiveness against the 501Y.V2 variant.[7]

Total number of people receiving vaccinations in South Africa as of 7 May 2021

  Unvaccinated population: 58,560,000 people (99.4%)
  Population who are fully Vaccinated: 381,171 people (7 May 2021) (0.6%)

Background

Rollout Strategy

National Vaccine Rollout Strategy[8]
Phase Priority group People Eligible (estimated)
Phase 1 (17 February 2021)
1 Front-line and health care workers +/- 1.2 Million People
Phase 2 (16 April 2021)
2 Essential workers, persons over 60-years and persons over 18-years with comorbidities +/- 5 Million People
Phase 3 (TBA)
3 Anyone over the age of 18 +/- 22.5 Million People

Vaccines On Order

South Africa has secured over 60 million doses of the vaccine, with 220 million doses to be manufactured locally for international and local distribution[9][10]

Vaccine name Approval progress Quantity Doses arrived Vaccine approved Began administering
Oxford–AstraZeneca EUA Suspended 1.5 million 1,000,000 Suspended Suspended
Johnson & Johnson Vaccine EUA Approved 30 million + 220 million 500,000 + 1,100,000 31 March 2021 (Full Authorization) 18 Feb 2021 (Phase III)
Pfizer vaccine EUA Approved 40 million 325,260 16 Mar 2021 Not yet
CoronaVac EUA Pending 5 Million (Offered) None Not yet Not yet
COVAX EUA Pending 9 million None Not yet Not yet

Vaccines in trial stage

On 17 March 2020, the South African Health Products Regulatory Authority announced that it would expedite review of treatments, vaccines and clinical trials.[11]

A team from 8 universities and 14 hospitals led by Helen Rees and Jeremy Nel from the University of the Witwatersrand participated in the World Health Organization Solidarity Clinical Trials that investigated medications.[12]

Vaccine Type (technology) Phase I Phase II Phase III
Johnson & Johnson COVID-19 vaccine Viral vector N/A Completed Completed
Pfizer–BioNTech COVID-19 vaccine RNA N/A Completed Completed
Oxford–AstraZeneca COVID-19 vaccine Viral vector Completed Completed N/A
Novavax COVID-19 vaccine Subunit N/A Completed In progress
GRAd-COV2 Viral vector N/A Completed In progress
ImmunityBio COVID-19 vaccine Viral vector In progress In progress Not yet

Johnson & Johnson (Ad26.COV2.S)

Both Phase II and Phase III trails were conducted in South Africa beginning late February 2020 and April 2021[13]

Phase II Trails, enrolled about 800 in Spain, United Kingdom and United States of America and proved to be 64% effective.[14][15]

Phase III Trails under Sisonke Protocal began early April enrolling 500,000 participants. This trial is currently underway and consists of a part of South Africa’s health workers and Phase 1 of the vaccine rollout.[16][17][18]

In January, Johnson & Johnson, which held trials for its Ad26.COV2.S vaccine in South Africa, reported the level of protection against moderate to severe COVID-19 infection was 72% in the United States, but 57% in South Africa.[19]

Pfizer–BioNTech (BNT162b2)

Both Phase II and Phase III trails were conducted in South Africa beginning late May 2020. Pfizers vaccine appeared to be 100% effective at preventing cases of the South African variant, B.1.351.[20][21][22]

On 17 February 2021, Pfizer announced neutralization activity was reduced by two thirds for the 501.V2 variant, while stating no claims about the efficacy of the vaccine in preventing illness for this variant could yet be made.[23][24][25]

Oxford–AstraZeneca (AZD1222)

Both Phase I and Phase II were conducted in South Africa.[26]Phase 1 and 2 trails began mid June 2020 consisting of about 2,130 participants.[27] The trail revealed that the vaccine does not have at least 60% efficacy against mild-moderate Covid-19 due to the B.1.351 (501Y.V2) variant. This resulted in the vaccine being suspended and the 1 million doses derived being sold to other Members of the African Union.[28][29][30]

On 6 February 2021, The Financial Times reported that provisional trial data from a study undertaken by South Africa'sUniversity of the Witwatersrand in conjunction with Oxford University demonstrated reduced efficacy of the Oxford–AstraZeneca COVID-19 vaccine against the 501.V2 variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal protection" in all but the most severe cases of COVID-19.[31]

On 7 February 2021, the Minister for Health for South Africa suspended the planned deployment of around 1 million doses of the vaccine whilst they examine the data and await advice on how to proceed.[32]

Novavax(NVX-CoV2373)

A Phase II Trail was conducted in from August 2020 to November 2021 in South Africa, consisting of 4,400 people was conducted, that showed that the vaccine was 51% effective, compared to 89% in the US [16][17][18]

The vaccine had efficacy of 51% against infections caused by the South African variant, among people who were HIV negative. The vaccine was only 43% effective in the group that included people who were HIV positive.[33]

ReiThera(GRAd-COV2)

Phase II and Phase III trails of the GRAd-COV2 vaccine are being conducted in South Africa.[34][35]

ImmunityBio (ImmunityBio)

The BioVac Institute, a state-backed South African vaccine company, plans to use a deal it won to manufacture coronavirus vaccines. The contract with American based ImmunityBio Inc is currently conducting phase 1 vaccine trials with their hAd5 vaccine in the United States and South Africa.[36][37][38]

ImmunityBio is currently conducting Phase I and Phase II trails. Trails began January 2021 consisting of about only 35 participants in Phase I.[39][26][39]

Johnson & Johnson Consignment (Phase III)

Consignment 1
1 80,000 Doses 17 February 2021 Fully Used
Consignment 2
2 80,000 Doses 27 February 2021 Fully Used
Consignment 3
3 86,000 Doses 7 March 2021 Fully Used
3a 40,000 Doses 13 March 2021 Fully Used
3b 66,000 Doses 20 March 2021 Fully Used
Consignment 4
4 200,000 Doses 11 April 2021 In Use

Johnson & Johnson Consignment (Full Authorization)

Consignment 1 (Manufactured Locally)
1 1 099 200 Doses Mid May Stock Manufactured, Held for Safety Assessment[40]
2 900 000 Doses TBA (May) In Manufacturing
3 900 000 Doses TBA (June)
Consignment 2
1 9 100 000 Doses Q3 2021 [41]
Consignment 3
1 19 100 000 Doses Q4 2021 [41]

Oxford-AstraZeneca Consignment

Consignment 1 [42]
1a 1,000,000 Doses 1 February 2021 Received
1b 500,000 Doses 14 February 2021 Canceled and Refunded
1c -1,000,000 Doses 20 February 2021 1,000,000 Doses Sold

Pfizer-BioNTech Consignment

Consignment 1
1 325,260 Doses 3 May 2021 Delivered
2 325,260 Doses 10 May 2021 To Be Delivered
3 325,260 Doses 17 May 2021 In Manufacturing
4 325,260 Doses 24 May 2021 In Manufacturing
Consignment 2
1 636,480 Doses 31 May 2021 In Manufacturing
2 636,480 Doses 7 June 2021 In Manufacturing
3 636,480 Doses 14 June 2021 In Manufacturing
4 636,480 Doses 21 June 2021 In Manufacturing
5 636,480 Doses 28 June 2021 In Manufacturing
6 636,480 Doses 5 July 2021 In Manufacturing
Consignment 3 [41]
Initial 8 519 940 Doses Q3 2021
Incremental 8 000 460 Doses
Consignment 4 [41]
Initial 6 996 600 Doses Q4 2021

History

Timeline

February 2021

File:Oxford-AstraZeneca Vaccines Arrive in South Africa.jpg
Oxford-AstraZeneca Vaccines Arrive in South Africa

On 1 February 2021, 1 million doses of the Oxford AstraZeneca vaccine at O. R. Tambo International Airport sent by the Serum Institute of India.[43][44][45]

On 7 February 2021, it was announced that the Oxford–AstraZeneca COVID-19 vaccine did not work well in protecting clinical trial participants from mild or moderate illness caused by the 501.V2 variant. The vaccination program was announced to be put on a hold.[46][47][48]

On 16 February 2021, South Africa received its first consignment of 80,000 doses of the Johnson & Johnson vaccine.[49]

On 17 February 2021, the national COVID vaccination program was officially rolled out, beginning at Khayelitsha District Hospital in the Western Cape Province where healthcare workers, the President Cyril Ramaphosa and Minister of Health Zweli Mkhize were given shots of the Johnson & Johnson/Janssen vaccine.[50][51][52]

On 27 February 2021, South Africa had received its second consignment of 80,000 doses of the Johnson & Johnson vaccine.[53][54]

March 2021

On 5 March 2021, the number of doses administered surpassed 100,000.[55]

On 13 March 2021, South Africa received Part 1 of its third consignment of 40,000 Johnson & Johnson COVID-19 vaccine.[56][57]

On 17 March 2021, South African Health Products Regulatory Authority (SAHPRA) approved the Pfizer/BioNTech coronavirus vaccine for use.[58][59][60][61]

On 18 March 2021, South Africa received Part 2 of its third consignment of 66,000 Johnson & Johnson vaccine.[62][63]

On 19 March 2021, ImmunityBio announced that they will be conducting Phase 1 vaccine trials with their hAd5 vaccine in the United States and South Africa.[64][65]

On 21 March 2021, South Africa sold and began transporting its 1 million doses of Oxford-AstraZeneca vaccine to other African Union Members. Concerns over the rollout of the vaccine in African countries have been raised, as the 501Y.V2 variant speeds through African countries, with South Africa Suspending the vaccine after a trial proved the vaccine to be ineffective.[66][67][68][69][42]

On 29 March 2020, the manufacturing of 220 million doses of the Johnson & Johnson vaccine was approved to begin at the Aspen Pharmacare manufacturing facility in Gqeberha, Eastern Cape.[70][71]

April 2021

On 6 April 2021, the government officially signed a deal with Pfizer for 20 million vaccines expected to begin arriving by the end of April.[72][73]

On 13 April 2021, Minister of Health Zweli Mkhize announced the suspension of Johnson & Johnson COVID-19 vaccine use following health concerns raised by the Food and Drug Administration (FDA).[74][75][76]

On 16 April 2021, The EVDS platform opened for Phase 2, allowing essential workers and the elderly to register.[77][78][79]

On 17 April 2021, The government announced that the first batch of 325,260 Doses of Pfizer vaccines would arrive on 3 May 2021. From there the same amount of doses are expected to arrive weekly, until 31 May 2021, where the number of daily doses delivered will increase to 636,480 weekly.[7]

On 23 April 2021, 500,000 Doses of the Johnson and Johnson vaccine were delivered under the early access program (Sisonke Programme), with a further 1,000,000 million doses to arrive in April.[74][80]

On 24 April 2021, Aspen Pharmacare announced that 1.1 million doses of the Johnson & Johnson vaccine were due for release and to be used by South Africa.[81]

On 26 April 2021, the government announced that the use of the Johnson & Johnson COVID-19 vaccine would resume on Wednesday, 28 April 2021 with vaccination sites expanded to 95 sites countrywide.[80]

On 28 April 2021, the Johnson & Johnson vaccines suspension was lifted, and given the full approval for use by SAPRAH.[82][83][84]

May 2021

File:Pfizer Vaccine arrive in South Africa.jpg
Pfizer-BioNTech Vaccine arrives in South Africa

On 2 May 2021, the government announced that the first 1.1 million doses of the Johnson & Johnson vaccine would receive an extended safety assessment, in line with international regulators, and stock would be released in mid May. [40]

On 3 May 2021, the first batch of 325,260 Doses of the Pfizer vaccine arrived at O.R Tambo International Airport. The vaccines were then sent to the National Control Laboratory for quality assurance.[85][86][87][88]

Vaccine effectiveness

Further information: 501.V2 variant

Many currently-available vaccines are less effective against the 501Y.V2 variant of the virus than they are against other variants.

Johnson & Johnson (Ad26.COV2.S)

In January, Johnson & Johnson, which held trials for its Ad26.COV2.S vaccine in South Africa, reported the level of protection against moderate to severe COVID-19 infection was 72% in the United States, but 57% in South Africa.[89]

After Phase III trails in South Africa completed, Johnson and Johnson is received Section 21 approval from SAHPRA on 31 March 2021.

In a manufacturing deal, Johnson and Johnson has began to manufacture 220 million vaccines at the Aspen Pharmacare manufacturing facility in Gqeberha, Eastern Cape. They plan to distribute the vaccine to other African countries with 30 million to go to South Africa.[90][71][70]

Oxford–AstraZeneca (AZD1222)

On 6 February 2021, The Financial Times reported that provisional trial data from a study undertaken by South Africa's University of the Witwatersrand in conjunction with Oxford University demonstrated reduced efficacy of the Oxford–AstraZeneca COVID-19 vaccine against the 501.V2 variant. The study found that in a sample size of 2,000 the AZD1222 vaccine afforded only "minimal protection" in all but the most severe cases of COVID-19.[69]

On 7 February 2021, the government suspended the planned deployment of around 1 million doses of the vaccine whilst they examined the data and awaited advice on how to proceed.[91] The South African government subsequently cancelled the use of the vaccine, selling its supply to other African countries, and switched its vaccination program to use the Johnson & Johnson COVID-19 vaccine.[92][93][94][a]

Sputnik V (Gam-COVID-Vac)

The South African Health Products Regulatory Authority (SAHPRA) has confirmed that it has received documentation for the vaccine developed by the Gamaleya Institute in Russia.[95]

Sputnik V is one of three Covid vaccines worldwide with an efficacy higher than 90% in symptomatic cases. They are still in the process of testing its effectiveness against the 501Y.V2 variant of the virus.[96]

Pfizer–BioNTech (BNT162b2)

On 17 February 2021, Pfizer announced neutralization activity was reduced by two thirds for the 501.V2 variant, while stating no claims about the efficacy of the vaccine in preventing illness for this variant could yet be made.[97]

On 16 March 2021, The South African Health Products Regulatory Authority (SAHPRA) approved the Pfizer-BioNTech vaccine for section 21 Emergency Use Authorisation.[98]

A trial ending in March 2021 of the Pfizer-BioNTech's COVID-19 vaccine appeared to be 100% effective at preventing cases of the South African 501Y.V2 variant. The trial consisted of 800 people, with a total of 9 cases, all in the placebo group[99][100]

Pfizer–BioNTech vaccine

Moderna (mRNA-1273)

In February, Moderna reported that the current vaccine produced only one-sixth of the antibodies in response to the South African variant compared with the original virus. They have launched a trial of a new vaccine to tackle the South African 501.V2 variant.[101]

Sinopharm (BBIBP-CorV)

Other African countries have begun the roll out of the Sinopharm, with Morocco, Egypt, The Seychelles and Zimbabwe, have begun the mass rollout of the vaccine.[102] So far, it has proven resistant to the 501Y.V2 variant, as seen in Zimbabwe.[103]

CoronaVac (Sinovac)

CoronaVac is yet to be approved for use by the South African Health Products Regulatory Authority (SAHPRA).[104]

So far, Sinovac has offered to supply South Africa with 5 million doses of the vaccine.[105]

Covaxin (BBV152)

Bharat Biotech, producers of the Covaxin vaccine, have said that they can modify the vaccine against coronavirus South African variant within 15 days.[106]

CoviVac (КовиВак)

The CoviVac vaccine Information has not been delivered to the South African government yet.[107]

EpiVacCorona (EpiVacCorona)

The EpiVacCorona vaccine Information has not been delivered to the South African government yet.[108]

RBD-Dimer (ZF2001)

The RBD-Dimer vaccine Information is in the process of being delivered to the South African Government.

Novavax (V2373)

A study on the NVX-CoV2373 Novavax vaccine showed 60% efficacy (for HIV-negative participants) in South Africa, compared to 90% efficacy in Britain.[109][110]

ImmunityBio (ImmunityBio)

The BioVac Institute, a state-backed South African vaccine company, plans to use a deal it won to manufacture coronavirus vaccines. The contract with American based ImmunityBio Inc is currently conducting phase 1 vaccine trials with their hAd5 vaccine in the United States and South Africa.[111]

ImmunityBio and BioVac plan to distribute the vaccines throughout South African and Africa.[112][113]

Progress

Vaccines distribution

As of 7 May 2021 18:00
100,000
200,000
300,000
400,000
  •   Johnson&Johnson
  •   Pfizer–BioNTech
  •   Moderna
  •   Oxford-AstraZeneca

Cumulative vaccinations in South Africa

Graph of cumulative doses administered across the country

  Total vaccination doses administered across the country    vaccinated (1st dose only)    Fully vaccinated[b]

Date Doses Administered Vaccinated (1 Dose) Fully Vaccinated Ref
17 February 2021 0 0 0 [114]
18 February 2021 2260 0 2260 [115]
19 February 2021 6524 0 6524 [116]
20 February 2021 10414 0 10414 [117]
21 February 2021 15388 0 15388 [118]
22 February 2021 23059 0 23059 [119]
23 February 2021 32315 0 32315 [120]
24 February 2021 41809 0 41809 [121]
25 February 2021 52647 0 52647 [122]
26 February 2021 63648 0 63648 [123]
27 February 2021 67303 0 67303 [124]
28 February 2021 70527 0 70527 [125]
1 March 2021 73047 0 73047 [126]
2 March 2021 76037 0 76037 [127]
3 March 2021 83570 0 83570 [128]
4 March 2021 92029 0 92029 [129]
5 March 2021 100108 0 100108 [130]
6 March 2021 101573 0 101573 [131]
7 March 2021 101841 0 101841 [132]
8 March 2021 107054 0 107054 [133]
9 March 2021 118247 0 118247 [134]
10 March 2021 128887 0 128887 [135]
11 March 2021 138014 0 138014 [136]
12 March 2021 145215 0 145215 [137]
13 March 2021 145544 0 145544 [138]
14 March 2021 145544 0 145544 [139]
15 March 2021 147753 0 147753 [140]
16 March 2021 157286 0 157286 [141]
17 March 2021 168413 0 168413 [142]
18 March 2021 177275 0 177275 [143]
19 March 2021 182983 0 182983 [144]
20 March 2021 182983 0 182983 [145]
21 March 2021 182983 0 182983 [146]
22 March 2021 182983 0 182983 [147]
23 March 2021 194257 0 194257 [148]
24 March 2021 207808 0 207808 [149]
25 March 2021 220129 0 220129 [150]
26 March 2021 231002 0 231002 [151]
27 March 2021 231605 0 231605 [152]
28 March 2021 239665 0 239665 [153]
29 March 2021 251707 0 251707 [154]
30 March 2021 263878 0 263878 [155]
31 March 2021 269102 0 269102 [156]
1 April 2021 269102 0 269102 [157]
2 April 2021 269102 0 269102 [158]
3 April 2021 269102 0 269102 [159]
4 April 2021 269102 0 269102 [160]
5 April 2021 269102 0 269102 [161]
6 April 2021 272438 0 272438 [162]
7 April 2021 278909 0 278909 [163]
8 April 2021 283629 0 283629 [164]
9 April 2021 288368 0 288368 [165]
10 April 2021 288406 0 288406 [166]
11 April 2021 288406 0 288406 [167]
12 April 2021 289787 0 289787 [168]
13 April 2021 292623 0 292623 [169]
14 April 2021 292623 0 292623 [170]
15 April 2021 292623 0 292623 [171]
16 April 2021 292623 0 292623 [172]
17 April 2021 292623 0 292623 [173]
18 April 2021 292623 0 292623 [174]
19 April 2021 292623 0 292623 [175]
20 April 2021 292623 0 292623 [176]
21 April 2021 292623 0 292623 [177]
22 April 2021 292623 0 292623 [178]
23 April 2021 292623 0 292623 [179]
24 April 2021 292623 0 292623 [180]
25 April 2021 292623 0 292623 [181]
26 April 2021 292623 0 292623 [182]
27 April 2021 292623 0 292623 [183]
28 April 2021 298153 0 298153 [184]
29 April 2021 307591 0 307591 [185]
30 April 2021 317656 0 317656 [186]
1 May 2021 318670 0 318670 [187]
2 May 2021 318670 0 318670 [188]
3 May 2021 329098 0 329098 [189]
4 May 2021 339655 0 339655 [190]
5 May 2021 353181 0 353181 [191]
6 May 2021 366101 0 366101 [192]
7 May 2021 381171 0 381171 [193]

Daily vaccinations chart of South Africa

Distribution

Vaccines administered per pharmaceutical company as of 7 May 2021

  Johnson & Johnson (381,171) (100%)
  Pfizer–BioNTech (0) (0%)
  Oxford–AstraZeneca (0) (0%)
  (0) (0%)
Vaccination Sites in South Africa

Doses administration by vaccine type in South Africa

Graph of cumulative doses administered by vaccine type

   Johnson & Johnson    Pfizer-BioNTech    Oxford-AstraZeneca[c]

The Covid-19 Vaccine can be obtained at 96 different hospitals nation-wide, with it to increase to over 1,000 locations, as Phase II progress ramps up.[194][195][d]

So far it’s planed that all Click’s and Dischem’s aswell as all pharmacies and hospitals nation wide in South Africa will be used to distribute vaccines.

Hospitals (Currently In Use)

Eastern Cape

  • Livingston Hospital
  • Nelson Mandela Academic Hospital
  • Frere Hospital
  • Netcare Greenacres Hospital

Free State

  • Universitas (C) Hospital
  • Pelonomi Hospital
  • Life Rosepark Hospital
  • Fezi Ngumbentombi
  • Bongani Hospital

Gauteng

  • Chris Hani Baragwanath Hospital
  • Steve Biko Academic Hospital
  • Ahmed Kathrada Private Hospital
  • Charlotte Maxeke Hospital
  • Dr George Mukhari Hospital
  • Netcare Milpark Hospital

KwaZulu-Natal

  • Inkosi Albert Luthuli Central Hospital
  • Prince Mshiyeni Memorial Hospital
  • General Justice Gizenga Mpanza
  • Edendale Hospital
  • Madadeni Hospital
  • Netcare St. Augustine's Hospital

Limpopo

  • Pietersburg Hospital
  • Mankweng Hosptial
  • Tshilidzini Hospital
  • Donald Fraser Hospital
  • Malamulele Hospital
  • Mediclinic Polokwane
  • Netcare Pholoso Hospital
  • St. Rita's Hospital

Mpumalanga

  • Rob Ferreira Hospital
  • Witbank Hospital
  • Ermelo Hospital
  • Life Cosmos Hospital
  • Mediclinic Nelspruit
  • Mapulaneng Hospital

North West

  • Klerksdorp-Tshepong Tertiary Hospital
  • Job Shimankana Tabane Hospital

Northern Cape

  • Robert Mangaliso Sobukwe Hospital
  • Mediclinic Upington

Western Cape

  • Groote Schuur Hospital
  • Tygerberg Hospital
  • Khayelitsha District Hospital
  • Gatesville Melomed
  • George Hospital
  • Karl Bremmer Hospital
  • Paarl Hospital
  • Worcester Hospital

Notes

  1. ^ South Africa’s Oxford-AstraZeneca vaccine was sold to African Union members and the additional 500,000 Doses were canceled
  2. ^ Recipients have received both doses
  3. ^ The Oxford-AstraZeneca vaccine is current suspended
  4. ^ Private Sector included

External links

Vaccine Enrollment Platform

See also

References

  1. ^ "COVID-19 Coronavirus vaccine strategy | South African Government". www.gov.za. Retrieved 19 March 2021.
  2. ^ Writer, Staff. "South Africa sets aside extra R4 billion for Covid-19 vaccines and grants". Retrieved 4 May 2021.
  3. ^ "Budget 2021: R10 billion allocated for Covid-19 vaccines". www.iol.co.za. Retrieved 5 March 2021.
  4. ^ Subramany, Deshnee. "A list of all the COVID-19 vaccine sites across South Africa". ewn.co.za. Retrieved 5 March 2021.
  5. ^ "SA's COVID-19 Vaccination Rollout Kicks Off In Khayelitsha - SA Corona Virus Online Portal". SA Corona Virus Online Portal. Retrieved 3 March 2021.
  6. ^ "Update On Covid-19 (06th May 2021) - SA Corona Virus Online Portal". SA Corona Virus Online Portal. Retrieved 7 May 2021.
  7. ^ a b Felix, Jason. "First batch of Pfizer Covid-19 vaccine set to arrive in May, Mkhize tells Parliament". News24. Retrieved 18 April 2021.
  8. ^ Kobedi, Puseletso (2 February 2021). "COVID-19 Vaccine Rollout Strategy FAQ". NICD. Retrieved 10 March 2021.
  9. ^ "SA has secured more than 40 million Covid-19 vaccine doses - Ramaphosa". www.iol.co.za. Retrieved 6 March 2021.
  10. ^ "South Africa has secured 51 million vaccine doses - Mkhize". www.iol.co.za. Retrieved 9 April 2021.
  11. ^ "SAHPRA responds to coronavirus (COVID-19): Medicines/medical devices supply challenges" (PDF). South African Health Products Regulatory Authority. 17 March 2020. Archived (PDF) from the original on 28 July 2020. Retrieved 17 April 2020.
  12. ^ Baleta, Adele (1 April 2020). "COVID-19: SA to start enrolling patients in landmark WHO trial". Spotlight. Archived from the original on 29 June 2020. Retrieved 4 May 2020.
  13. ^ "Janssen (Johnson & Johnson): Ad26.COV2.S – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 8 May 2021.
  14. ^ "J&J vaccine works better against SA variant than previously reported". BusinessInsider. Retrieved 8 May 2021.
  15. ^ Janssen Vaccines & Prevention B.V. (16 March 2021). "An Open-label, Phase 2 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S in Healthy Pregnant Participants". {{cite journal}}: Cite journal requires |journal= (help)
  16. ^ a b Wits Health Consortium (Pty) Ltd (13 April 2021). "Open-label, Single-arm Phase 3B Implementation Study to Monitor the Effectiveness of the Single-dose Ad26.COV2.S COVID-19 Vaccine Among Health Care Workers in South Africa (VAC31518COV3012)". National Department of Health of South Africa, National Institute for Communicable Diseases, South Africa, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, Fred Hutchinson Cancer Research Center, Hutchinson Center Research Institute of South Africa (HCRISA), Janssen Vaccines & Prevention B.V. {{cite journal}}: Cite journal requires |journal= (help)
  17. ^ a b "Health care workers urged to vaccinate in Sisonke Protocol". SAnews. 7 May 2021. Retrieved 8 May 2021.
  18. ^ a b "Janssen (Johnson & Johnson): Ad26.COV2.S – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 8 May 2021.
  19. ^ "Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial". jnj.com. 29 January 2021. Retrieved 29 January 2021.
  20. ^ "Pfizer/BioNTech: BNT162b2 – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 8 May 2021.
  21. ^ BioNTech SE (29 April 2021). "A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS". Pfizer. {{cite journal}}: Cite journal requires |journal= (help)
  22. ^ "Trial: Pfizer COVID Vax Effective Against South African Variant". www.medpagetoday.com. 1 April 2021. Retrieved 8 May 2021.
  23. ^ Liu, Yang; Liu, Jianying; Xia, Hongjie; Zhang, Xianwen; Fontes-Garfias, Camila R.; Swanson, Kena A.; Cai, Hui; Sarkar, Ritu; Chen, Wei; Cutler, Mark; Cooper, David; Weaver, Scott C.; Muik, Alexander; Sahin, Ugur; Jansen, Kathrin U.; Xie, Xuping; Dormitzer, Philip R.; Shi, Pei-Yong (17 February 2021). "Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report". New England Journal of Medicine. doi:10.1056/nejmc2102017. Retrieved 25 February 2021.
  24. ^ "Phase III trial of Pfizer-BioNTech Covid-19 vaccine starts in South Africa". www.clinicaltrialsarena.com. Retrieved 8 May 2021.
  25. ^ "What are the India, Brazil, South Africa and UK variants?". BBC News. 8 May 2021. Retrieved 8 May 2021.
  26. ^ a b "Janssen (Johnson & Johnson): Ad26.COV2.S – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 8 May 2021.
  27. ^ University of Oxford (23 November 2020). "An Adaptive Phase I/II Randomized Placebo-controlled Trial to Determine Safety, Immunogenicity and Efficacy of Non-replicating ChAdOx1 SARS-CoV-2 Vaccine in South African Adults Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV". Medical Research Council, South Africa, Bill and Melinda Gates Foundation, Wits Health Consortium (Pty) Ltd, University of Witwatersrand, South Africa. {{cite journal}}: Cite journal requires |journal= (help)
  28. ^ Voysey, Merryn; Clemens, Sue Ann Costa; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L.; Bhorat, Qasim E.; Bibi, Sagida (9 January 2021). "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK". The Lancet. 397 (10269): 99–111. doi:10.1016/S0140-6736(20)32661-1. ISSN 0140-6736. PMID 33306989.
  29. ^ "Latest - Oxford Covid-19 vaccine trial results - Wits University". www.wits.ac.za. Retrieved 8 May 2021.
  30. ^ "South African Oxford AstraZeneca Covid-19 vaccine study a global game-changer". EurekAlert!. Retrieved 8 May 2021.
  31. ^ Booth, William; Johnson, Carolyn Y. (7 February 2021). "South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant". The Washington Post. London. Retrieved 8 February 2021. South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.
  32. ^ "Covid: South Africa halts AstraZeneca vaccine rollout over new variant". BBC News. 8 February 2021. Retrieved 12 February 2021.
  33. ^ "Novavax vaccine shows 51% efficacy against South African variant - study". The Jerusalem Post | JPost.com. Retrieved 8 May 2021.
  34. ^ "ReiThera: GRAd-COV2 – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 8 May 2021.
  35. ^ "ReiThera GRAd-COV2 vaccine". clinicaltrialsregister. Retrieved 8 May 2021.{{cite web}}: CS1 maint: url-status (link)
  36. ^ "Covid-19 to Serve as Platform for South African Vaccine Industry". Bloomberg.com. 19 March 2021. Retrieved 20 March 2021.
  37. ^ Fisher, Shamiela. "Nzimande excited about vaccine partnership between Biovac & ImmunityBio". ewn.co.za. Retrieved 20 March 2021.
  38. ^ Sguazzin, Antony. "SA's BioVac to use deal with US-based ImmunityBio to boost local vaccine creation, CEO says". Fin24. Retrieved 20 March 2021.
  39. ^ a b ImmunityBio, Inc. (9 March 2021). "Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of a Prophylactic COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults (ProVIVA-SA-1)". {{cite journal}}: Cite journal requires |journal= (help)
  40. ^ a b "Media Statement: Update on Status of Delivery of Market Doses of Pfizer and Johnson and Johnson. @DrZweliMkhize". Twitter. Retrieved 2 May 2021.{{cite web}}: CS1 maint: url-status (link)
  41. ^ a b c d "Minister Zweli Mkhize confirms total of 1 567 513 cases of Coronavirus COVID-19 | South African Government". www.gov.za. Retrieved 28 April 2021.
  42. ^ a b "South Africa in shock after AstraZeneca vaccine rollout halted". BBC News. 9 February 2021. Retrieved 19 March 2021.
  43. ^ "FULL SPEECH | Ramaphosa drops alcohol sales ban, opens beaches and eases curfew. Here are 12 takeouts". News24. Retrieved 2 February 2021.
  44. ^ News, Eyewitness. "GALLERY: The arrival of hope as vaccines land in SA". ewn.co.za. Retrieved 5 March 2021. {{cite web}}: |last= has generic name (help)
  45. ^ Lindeque, Mia. "7 things you need to know about the Oxford-AstraZeneca vaccine". ewn.co.za. Retrieved 9 April 2021.
  46. ^ Mueller, Benjamin; Robbins, Rebecca; Chutel, Lynsey (7 February 2021). "AstraZeneca's Vaccine Does Not Work Well Against Virus Variant in South Africa". The New York Times. ISSN 0362-4331. Retrieved 8 February 2021.
  47. ^ Mueller, Benjamin; Robbins, Rebecca; Chutel, Lynsey (7 February 2021). "South Africa says AstraZeneca's vaccine doesn't work well against a variant". The New York Times. ISSN 0362-4331. Retrieved 9 April 2021.
  48. ^ Ray, Siladitya. "Report: South Africa Asks Indian Maker Of AstraZeneca Vaccine To Take Back One Million Doses". Forbes. Retrieved 9 April 2021.
  49. ^ "J&J vaccines arrive in SA on Tuesday night". TimesLIVE. Retrieved 5 March 2021.
  50. ^ "'Can I close my eyes?' Ramaphosa has Covid-19 jab with Khayelitsha hospital staff". TimesLIVE. Retrieved 17 February 2021.
  51. ^ Brandt, Kevin. "No tears: Ramaphosa gets his COVID-19 vaccine jab". ewn.co.za. Retrieved 18 March 2021.
  52. ^ News, A. B. C. "In switch, South Africa to give health workers J&J vaccine". ABC News. Retrieved 9 April 2021. {{cite web}}: |last= has generic name (help)
  53. ^ "Second batch of 80 000 doses of Johnson & Johnson vaccine arrives in SA". www.iol.co.za. Retrieved 3 March 2021.
  54. ^ Pietromarchi, Virginia. "South Africa launches vaccine roll-out with Johnson & Johnson jab". www.aljazeera.com. Retrieved 9 April 2021.
  55. ^ "SA hits vaccine milestone as 100,000 shots have now been administered". TimesLIVE. Retrieved 6 March 2021.
  56. ^ Persens, Lizell. "SA to receive more tranches of J&J vaccine this week, authorities say". ewn.co.za. Retrieved 18 March 2021.
  57. ^ Persens, Lizell. "SA to receive more tranches of J&J vaccine this week, authorities say". ewn.co.za. Retrieved 9 April 2021.
  58. ^ "South Africa approves another COVID-19 vaccine | eNCA". www.enca.com. Retrieved 18 March 2021.
  59. ^ "J&J Covid-19 Vaccine Approved in South Africa for Wider Use". Bloomberg.com. 1 April 2021. Retrieved 9 April 2021.
  60. ^ "South Africa approves another COVID-19 vaccine | eNCA". www.enca.com. Retrieved 9 April 2021.
  61. ^ Writer, Staff. "South Africa approves Pfizer Covid-19 vaccine for emergency use". Retrieved 19 March 2021.
  62. ^ "66 000 more doses of J&J Covid-19 vaccine touches down in South Africa". www.iol.co.za. Retrieved 22 March 2021.
  63. ^ Palm, Kaylynn. "More than 60k additional doses of J&J vaccine land in SA". ewn.co.za. Retrieved 22 March 2021.
  64. ^ Sguazzin, Antony. "SA's BioVac to use deal with US-based ImmunityBio to boost local vaccine creation, CEO says". Fin24. Retrieved 23 March 2021.
  65. ^ "Covid-19 to Serve as Platform for South African Vaccine Industry". Bloomberg.com. 19 March 2021. Retrieved 23 March 2021.
  66. ^ Monama, Tebogo. "SA to sell AstraZeneca vaccines to African Union to help 20 countries vaccinate health staff". News24. Retrieved 9 April 2021.
  67. ^ AfricaNews (23 March 2021). "South Africa sells Astrazeneca jabs to other AU member states". Africanews. Retrieved 9 April 2021.
  68. ^ "S. Africa sells its AstraZeneca vaccine doses to AU". news.yahoo.com. Retrieved 9 April 2021.
  69. ^ a b Booth, William; Johnson, Carolyn Y. (7 February 2021). "South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report 'minimal' protection against coronavirus variant". The Washington Post. London. Retrieved 8 February 2021. South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.
  70. ^ a b "'No setbacks.' SA factory on track to produce J&J vaccine". BusinessInsider. Retrieved 31 March 2021.
  71. ^ a b "COVID-19 vaccine: J&J commits 30 million doses for SA | eNCA". www.enca.com. Retrieved 31 March 2021.
  72. ^ "Covid-19: SA signs deal for 20 million Pfizer vaccine doses". News24. Retrieved 7 April 2021.
  73. ^ "SA signs deal for 20 million doses of Pfizer Covid-19 vaccine". www.iol.co.za. Retrieved 7 April 2021.
  74. ^ a b Writer, Staff. "South Africa suspends rollout of Johnson & Johnson Covid vaccine". Retrieved 15 April 2021.
  75. ^ Brandt, Kevin. "Mkhize to announce SA's response to global concern about J&J vaccine at 7pm". ewn.co.za. Retrieved 15 April 2021.
  76. ^ Kobedi, Puseletso (14 April 2021). "COVID-19 J&J Vaccine Rollout Temporarily on Hold". NICD. Retrieved 15 April 2021.
  77. ^ "Registration for COVID-19 vaccine now open for those over 60". SAnews. 16 April 2021. Retrieved 1 May 2021.
  78. ^ Lindeque, Mia. "COVID-19 vaccine registration for elderly S. Africans to open on Friday - Mkhize". ewn.co.za. Retrieved 1 May 2021.
  79. ^ "SA's vaccine registration portal opens to people 60 years and older – here's how to book your jab". BusinessInsider. Retrieved 1 May 2021.
  80. ^ a b "Health on the status of Coronavirus COVID-19 vaccine rollout in South Africa | South African Government". www.gov.za. Retrieved 26 April 2021.
  81. ^ "First locally made vaccines ready for rollout". TimesLIVE. Retrieved 1 May 2021.
  82. ^ "South Africa restarts inoculation with J&J's Covid-19 vaccine". www.pharmaceutical-technology.com. Retrieved 29 April 2021.
  83. ^ "SA government support for J&J programme lifts JSE". www.iol.co.za. Retrieved 29 April 2021.
  84. ^ "WRAP | J&J vaccination rollout resumes with warnings of side effects". TimesLIVE. Retrieved 29 April 2021.
  85. ^ "First batch of Pfizer vaccines arrive in South Africa | eNCA". www.enca.com. Retrieved 3 May 2021.
  86. ^ Ellis, Estelle (2 May 2021). "CORONAVIRUS: Zweli Mkhize announces imminent arrival of the first batch of the Pfizer Covid vaccine". Daily Maverick. Retrieved 3 May 2021.
  87. ^ Writer, Staff. "Some good news for South Africa's Covid-19 vaccine rollout". Retrieved 3 May 2021.
  88. ^ "Update On Status Of Delivery Of Market Doses Of Pfizer And Johnson And Johnson - SA Corona Virus Online Portal". SA Corona Virus Online Portal. Retrieved 6 May 2021.
  89. ^ "Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial". jnj.com. 29 January 2021. Retrieved 29 January 2021.
  90. ^ "Covid-19: SA plans to vaccinate 200 000 people a day - report". News24. Retrieved 31 March 2021.
  91. ^ "Covid: South Africa halts AstraZeneca vaccine rollout over new variant". BBC News. 8 February 2021. Retrieved 12 February 2021.
  92. ^ "South Africa sells AstraZeneca COVID-19 vaccines to other African countries". Reuters. 21 March 2021. Retrieved 23 March 2021.
  93. ^ "South Africa gets rid of 1 million AstraZeneca vaccine doses, but why?". RFI. 22 March 2021. Retrieved 23 March 2021.
  94. ^ Seleka, Ntwaagae. "Covid-19: SA finalising sale of 1m AstraZeneca vaccine doses to AU at price purchased from India". News24. Retrieved 4 April 2021.
  95. ^ "Sahpra begins evaluation of Russia's Sputnik V vaccine for use in SA". www.iol.co.za. Retrieved 20 March 2021.
  96. ^ Monama, Tebogo. "Covid-19: SA begins process to register Russia's Sputnik V vaccine". News24. Retrieved 20 March 2021.
  97. ^ Liu, Yang; Liu, Jianying; Xia, Hongjie; Zhang, Xianwen; Fontes-Garfias, Camila R.; Swanson, Kena A.; Cai, Hui; Sarkar, Ritu; Chen, Wei; Cutler, Mark; Cooper, David; Weaver, Scott C.; Muik, Alexander; Sahin, Ugur; Jansen, Kathrin U.; Xie, Xuping; Dormitzer, Philip R.; Shi, Pei-Yong (17 February 2021). "Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report". New England Journal of Medicine. doi:10.1056/nejmc2102017. Retrieved 25 February 2021.
  98. ^ Writer, Staff. "South Africa approves Pfizer Covid-19 vaccine for emergency use". Retrieved 19 March 2021.
  99. ^ "Trial: Pfizer COVID Vax Effective Against South African Variant". www.medpagetoday.com. 1 April 2021. Retrieved 4 April 2021.
  100. ^ "Pfizer, BioNTech say coronavirus vaccine highly effective against South African variant". www.thenews.com.pk. Retrieved 4 April 2021.
  101. ^ Kuchler, Hannah (25 January 2021). "Moderna develops new vaccine to tackle mutant Covid strain". Financial Times. Retrieved 30 January 2021.
  102. ^ "Other African countries are rapidly rolling out China's vaccine – as SA awaits more data". BusinessInsider. Retrieved 20 March 2021.
  103. ^ "Covid: South Africa variant now 'dominant' in Zimbabwe". BBC News. 16 February 2021. Retrieved 20 March 2021.
  104. ^ "China's Sinovac offers SA 5-million vaccine doses 'within weeks'". 702. Retrieved 20 March 2021.
  105. ^ "Sinovac May Supply South Africa With 5 Million Vaccines, Report Says". Bloomberg.com. 18 March 2021. Retrieved 20 March 2021.
  106. ^ Bhandari, Shashwat (23 February 2021). "Covaxin can neutralise South African variant 15 days Bharat Biotech big statement | India News – India TV". www.indiatvnews.com. Retrieved 20 March 2021.
  107. ^ Ellis, Ralph. "Vaccine Not as Effective Against S. African Variant". WebMD. Retrieved 20 March 2021.
  108. ^ "COVID-19: Latest global developments | eNCA". www.enca.com. Retrieved 20 March 2021.
  109. ^ "Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial". ir.novavax.com. 28 January 2021. Retrieved 30 January 2021.
  110. ^ "Novavax Covid-19 Vaccine Trial - Wits University". www.wits.ac.za. Retrieved 25 March 2021.
  111. ^ "Covid-19 to Serve as Platform for South African Vaccine Industry". Bloomberg.com. 19 March 2021. Retrieved 20 March 2021.
  112. ^ Fisher, Shamiela. "Nzimande excited about vaccine partnership between Biovac & ImmunityBio". ewn.co.za. Retrieved 20 March 2021.
  113. ^ Sguazzin, Antony. "SA's BioVac to use deal with US-based ImmunityBio to boost local vaccine creation, CEO says". Fin24. Retrieved 20 March 2021.
  114. ^ Gale, Nileen (17 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (17 FEB 2021)". NICD. Retrieved 10 April 2021.
  115. ^ Gale, Nileen (18 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (18 FEB 2021)". NICD. Retrieved 9 April 2021.
  116. ^ Gale, Nileen (19 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (19 FEB 2021)". NICD. Retrieved 9 April 2021.
  117. ^ Gale, Nileen (20 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (20 FEB 2021)". NICD. Retrieved 9 April 2021.
  118. ^ Gale, Nileen (21 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (21 FEB 2021)". NICD. Retrieved 9 April 2021.
  119. ^ Kobedi, Puseletso (22 February 2021). "Latest confirmed cases of COVID-19 in South Africa (22 Feb 2021)". NICD. Retrieved 9 April 2021.
  120. ^ Kobedi, Puseletso (23 February 2021). "Latest confirmed cases of COVID-19 in South Africa (23 Feb 2021)". NICD. Retrieved 9 April 2021.
  121. ^ Kobedi, Puseletso (24 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (24 FEB 2021)". NICD. Retrieved 9 April 2021.
  122. ^ Kobedi, Puseletso (25 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (25 FEB 2021)". NICD. Retrieved 9 April 2021.
  123. ^ Kobedi, Puseletso (26 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (26 FEB 2021)". NICD. Retrieved 9 April 2021.
  124. ^ Kobedi, Puseletso (27 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (27 FEB 2021)". NICD. Retrieved 9 April 2021.
  125. ^ Kobedi, Puseletso (28 February 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (28 FEB 2021)". NICD. Retrieved 9 April 2021.
  126. ^ Sibilanga, Lesego (1 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (1 MAR 2021)". NICD. Retrieved 9 April 2021.
  127. ^ Sibilanga, Lesego (2 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (2 MAR 2021)". NICD. Retrieved 9 April 2021.
  128. ^ Sibilanga, Lesego (3 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (3 MAR 2021)". NICD. Retrieved 9 April 2021.
  129. ^ Sibilanga, Lesego (4 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (4 MAR 2021)". NICD. Retrieved 9 April 2021.
  130. ^ Sibilanga, Lesego (5 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (5 MAR 2021)". NICD. Retrieved 9 April 2021.
  131. ^ Gale, Nileen (6 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (6 MAR 2021)". NICD. Retrieved 10 April 2021.
  132. ^ Sibilanga, Lesego (7 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (7 MAR 2021)". NICD. Retrieved 10 April 2021.
  133. ^ Gale, Nileen (8 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (8 MAR 2021)". NICD. Retrieved 10 April 2021.
  134. ^ Gale, Nileen (9 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (9 MAR 2021)". NICD. Retrieved 10 April 2021.
  135. ^ Gale, Nileen (10 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (10 MAR 2021)". NICD. Retrieved 10 April 2021.
  136. ^ Gale, Nileen (11 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (11 MAR 2021)". NICD. Retrieved 10 April 2021.
  137. ^ Gale, Nileen (12 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (12 MAR 2021)". NICD. Retrieved 10 April 2021.
  138. ^ Gale, Nileen (13 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (13 MAR 2021)". NICD. Retrieved 10 April 2021.
  139. ^ Gale, Nileen (14 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (14 MAR 2021)". NICD. Retrieved 10 April 2021.
  140. ^ Kobedi, Puseletso (15 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (15 MAR 2021)". NICD. Retrieved 10 April 2021.
  141. ^ Kobedi, Puseletso (16 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (16 MAR 2021)". NICD. Retrieved 10 April 2021.
  142. ^ Kobedi, Puseletso (17 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (17 MAR 2021)". NICD. Retrieved 10 April 2021.
  143. ^ Kobedi, Puseletso (18 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (18 MAR 2021)". NICD. Retrieved 10 April 2021.
  144. ^ Kobedi, Puseletso (19 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (19 MAR 2021)". NICD. Retrieved 10 April 2021.
  145. ^ Kobedi, Puseletso (20 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (20 MAR 2021)". NICD. Retrieved 10 April 2021.
  146. ^ Kobedi, Puseletso (21 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (21 MAR 2021)". NICD. Retrieved 10 April 2021.
  147. ^ Sibilanga, Lesego (22 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (22 MAR 2021)". NICD. Retrieved 10 April 2021.
  148. ^ Sibilanga, Lesego (23 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (23 MAR 2021)". NICD. Retrieved 10 April 2021.
  149. ^ Sibilanga, Lesego (24 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (24 MAR 2021)". NICD. Retrieved 10 April 2021.
  150. ^ Sibilanga, Lesego (25 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (25 MAR 2021)". NICD. Retrieved 10 April 2021.
  151. ^ Sibilanga, Lesego (26 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (26 MAR 2021)". NICD. Retrieved 10 April 2021.
  152. ^ Sibilanga, Lesego (27 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (27 MAR 2021)". NICD. Retrieved 10 April 2021.
  153. ^ Gale, Nileen (28 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (28 MAR 2021)". NICD. Retrieved 10 April 2021.
  154. ^ Gale, Nileen (29 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (29 MAR 2021)". NICD. Retrieved 10 April 2021.
  155. ^ Gale, Nileen (30 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (30 MAR 2021)". NICD. Retrieved 10 April 2021.
  156. ^ Gale, Nileen (31 March 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (31 MAR 2021)". NICD. Retrieved 10 April 2021.
  157. ^ Gale, Nileen (1 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (1 APRIL 2021)". NICD. Retrieved 10 April 2021.
  158. ^ Gale, Nileen (2 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (2 APRIL 2021)". NICD. Retrieved 10 April 2021.
  159. ^ Gale, Nileen (3 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (3 APRIL 2021)". NICD. Retrieved 10 April 2021.
  160. ^ Gale, Nileen (4 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (4 APRIL 2021)". NICD. Retrieved 10 April 2021.
  161. ^ Kobedi, Puseletso (5 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (5 APRIL 2021". NICD. Retrieved 10 April 2021.
  162. ^ Kobedi, Puseletso (6 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (6 APRIL 2021)". NICD. Retrieved 10 April 2021.
  163. ^ Kobedi, Puseletso (7 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (7 APRIL 2021)". NICD. Retrieved 10 April 2021.
  164. ^ Jimoh, Sinenhlanhla (8 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (8 APRIL 2021)". NICD. Retrieved 10 April 2021.
  165. ^ Gale, Nileen (9 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (9 APRIL 2021)". NICD. Retrieved 10 April 2021.
  166. ^ Jimoh, Sinenhlanhla (10 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (10 APR 2021)". NICD. Retrieved 15 April 2021.
  167. ^ Jimoh, Sinenhlanhla (11 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (11 APR 2021)". NICD. Retrieved 15 April 2021.
  168. ^ Sibilanga, Lesego (12 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (12 APR 2021)". NICD. Retrieved 20 April 2021.
  169. ^ Gale, Nileen (13 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (13 APR 2021)". NICD. Retrieved 20 April 2021.
  170. ^ Gale, Nileen (14 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (14 APR 2021)". NICD. Retrieved 20 April 2021.
  171. ^ Gale, Nileen (15 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (15 APR 2021)". NICD. Retrieved 20 April 2021.
  172. ^ Gale, Nileen (16 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (16 APR 2021)". NICD. Retrieved 20 April 2021.
  173. ^ Gale, Nileen (17 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (17 APR 2021)". NICD. Retrieved 20 April 2021.
  174. ^ Gale, Nileen (18 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (18 APR 2021)". NICD. Retrieved 20 April 2021.
  175. ^ Sibilanga, Lesego (19 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (19 APR 2021)". NICD. Retrieved 20 April 2021.
  176. ^ Sibilanga, Lesego (20 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (20 APR 2021)". NICD. Retrieved 29 April 2021.
  177. ^ Sibilanga, Lesego (21 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (21 APR 2021)". NICD. Retrieved 29 April 2021.
  178. ^ Sibilanga, Lesego (23 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (22 APR 2021)". NICD. Retrieved 29 April 2021.
  179. ^ Sibilanga, Lesego (23 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (23 APR 2021)". NICD. Retrieved 29 April 2021.
  180. ^ Sibilanga, Lesego (24 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (24 APR 2021)". NICD. Retrieved 29 April 2021.
  181. ^ Sibilanga, Lesego (25 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (25 APR 2021)". NICD. Retrieved 29 April 2021.
  182. ^ Jimoh, Sinenhlanhla (26 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (26 APR 2021)". NICD. Retrieved 29 April 2021.
  183. ^ Gale, Nileen (27 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (27 APR 2021)". NICD. Retrieved 29 April 2021.
  184. ^ Gale, Nileen (28 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (28 APR 2021)". NICD. Retrieved 29 April 2021.
  185. ^ Sibilanga, Lesego (29 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (29 APR 2021)". NICD. Retrieved 29 April 2021.
  186. ^ Sibilanga, Lesego (30 April 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (30 APR 2021)". NICD. Retrieved 30 April 2021.
  187. ^ Kobedi, Puseletso (1 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (1 May 2021)". NICD. Retrieved 2 May 2021.
  188. ^ Kobedi, Puseletso (2 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (2 MAY 2021)". NICD. Retrieved 3 May 2021.
  189. ^ Gale, Nileen (3 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (3 MAY 2021)". NICD. Retrieved 4 May 2021.
  190. ^ Gale, Nileen (4 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (4 MAY 2021)". NICD. Retrieved 5 May 2021.
  191. ^ Gale, Nileen (5 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (5 MAY 2021)". NICD. Retrieved 6 May 2021.
  192. ^ Gale, Nileen (6 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (6 MAY 2021)". NICD. Retrieved 6 May 2021.
  193. ^ Gale, Nileen (7 May 2021). "LATEST CONFIRMED CASES OF COVID-19 IN SOUTH AFRICA (7 MAY 2021)". NICD. Retrieved 8 May 2021.
  194. ^ News, Eyewitness. "The 18 sites in SA where the first J&J vaccinations will take place". ewn.co.za. Retrieved 5 March 2021. {{cite web}}: |last= has generic name (help)
  195. ^ Subramany, Deshnee. "A list of all the COVID-19 vaccine sites across South Africa". ewn.co.za. Retrieved 18 March 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_in_South_Africa&oldid=1022141945"